FOR IMMEDIATE RELEASE
National Vaccine Program Office, Novartis Vaccines and Diagnostics,
and Disney Institute to Give Keynotes at Annual Global ISPE Event
(TAMPA, FLORIDA, USA, 28 SEPTEMBER 2010) – ISPE, a global not-for-profit association of 22,000 pharmaceutical science and manufacturing professionals, announced today that it has secured Bruce G. Gellin, MD, MPH, Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office (NVPO), Matthew R. Stober, Chemical Engineer and Global Head, Technical Operations for Novartis Vaccines and Diagnostics, and the Disney Institute to give keynote presentations at the ISPE 2010 Annual Meeting being held 7-10 November at the Swan and Dolphin Resort, Orlando, Florida, USA.
“The Keynote Session—with its impressive list of highly respected and credentialed speakers—is just one of the many opportunities at ISPE 2010 Annual Meeting for pharmaceutical professionals to learn about emerging global industry trends and practices,” said Robert P. Best, President and CEO of ISPE. “The meeting’s content-rich education sessions also provide critical information and interaction with industry experts and regulatory authorities. Our theme this year is, ‘Discovering What’s Next,’ which is a concept that’s at the forefront of our Members’ agendas. The ISPE 2010 Annual Meeting will give them a forum to work together to discover what’s next for the pharmaceutical industry.”
Information About the Speakers
Dr. Bruce Gellin, MD, MPH is Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office (NVPO), and is one of the United States’ top experts on vaccines and infectious diseases. NVPO was created by the US Congress to provide leadership and coordination among Federal agencies and other immunization stakeholders, including states and municipalities, health care providers, and private-sector entities such as vaccine manufacturers.
Matthew R. Stober is a Chemical Engineer and currently Global Head, Technical Operations for Novartis Vaccines and Diagnostics. Previously, he was Vice President, Biopharmaceutical Operations for GlaxoSmithKline responsible for the management of commercial manufacturing sites in the US and UK as well as the development and implementation of global biopharmaceutical manufacturing strategy. Prior to that, he worked for both Merck and Pfizer.
The Disney Institute: Experience the Business Behind the Magic. Don’t let a down economy be a time for caution. This is a chance to outpace your competition. In “Leading through Turbulent Times,” explore the proven best practices that underlie the Disney approach to sustaining excellence during turbulent times. We will provide you with creative strategies to weather the economic climate and effectively meet the challenges of today’s business environment. These strategies can easily be adapted to any organization or industry to help retain customers, engage employees, and position your organization for future ongoing success.
ISPE 2010 Annual Meeting Highlights
Education sessions at the 2010 ISPE Annual Meeting will follow 11 tracks of interest: Facilities and Equipment, Outsourcing, Retooling for Operational Excellence, Successful Delivery, Regulatory, Young Professionals, Information Systems, Sustainability, Project Management, Investigational Products, and the brand-new Hot Topics track. With Hot Topics, ISPE incorporates late-breaking content to the Annual Meeting education sessions using last-minute topic submissions from Members collected throughout the summer. Hot Topics ensures that Members have the opportunity to learn about current industry topics as part of the ISPE Annual Meeting agenda. Networking activities, exhibits, and special events will also allow for one-on-one time with colleagues for further knowledge and best practice sharing.
Announcement of the 2010 Overall Facility of the Year Awards Winner. The overall 2010 Facility of the Year Awards winner will be announced during the Keynote Address. The overall winner was chosen by an independent judging panel of experts with global expertise in all facets of the pharmaceutical manufacturing industry and will be announced for the first time from among 6 Category Winners. The Category winners for 2010 are Biogen Idec - Operational Excellence Winner; Genentech - Project Execution Winner; MannKind Corporation - Equipment Innovation Winner and Process Innovation Winner; Pfizer Biotechnology Ireland - Sustainability Winner, and Pfizer Ireland Pharmaceuticals - Facility Integration Winner.
ISPE Membership Luncheon and Awards Ceremony will be held 9 November, and reveal the winners of the ISPE Member of the Year, Company of the Year, Chapter or Affiliate of the Year, and International Student Poster Competition awards, among many others.
3rd Annual COP Night will be held 8 November. This year, ISPE’s 19 Communities of Practice (COPs) will hold a Beach Bash and General Reception, at which COP members will be able to relax and network while participating in an experience customized to their interests.
Table Top Exhibition will be held 7-9 November to showcase products and services from the industry. For information, contact John Phillips at +1-813-739-2292 or Daniel Murphy at +1-813-739-2274, or click here.
Click here or call +1-813-960-2105 for more information or to register for this premiere event.
ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 24,000 technical professionals working in or serving the manufacturing sector or drug development in the pharmaceutical industry in 90 countries. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop their technical knowledge, exchange practical experience within their community, enhance their professional skills, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE offers online learning opportunities for a global audience and has its worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; an Asia Pacific office in Singapore; and its newest office in Shanghai, China. Visit www.ISPE.org for additional Society news and information.
Reimagining Medicine – The Novartis Mission
Tuesday, 26 Jul 2016 13.07
GAMP Cloud Special Interest Group Concept Papers
Monday, 25 Jul 2016 14.07
Drug Shortages Reveals Progress – First Drop Since 2012
Wednesday, 20 Jul 2016 17.07